Decision Support · Side-by-side

BERG (BPGbio) vs Euretos AI Platform. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

BERG (BPGbio)

Euretos AI Platform

Best overall

Neither BERG (BPGbio) nor Euretos AI Platform is for everyday users — both are enterprise-grade drug discovery tools for large pharma teams. BERG wins for labs with deep multi-omics data and a need for causal AI, while Euretos is better for teams that want a broad, pre-integrated knowledge graph for target discovery. The single biggest difference: BERG requires your own high-quality multi-omics data, whereas Euretos comes with a massive built-in data lake.

BERG (BPGbio)

#4528 of 3,826 Web

Euretos AI Platform

#4698 of 3,826 Web

Scores at a glance

BERG (BPGbio)Euretos AI PlatformPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose BERG (BPGbio) if

You are a large pharma company with a rich collection of multi-omics data (proteomics, metabolomics, genomics) and want to find truly novel drug targets
You need causal AI to understand why a disease happens, not just what genes are correlated with it
You have a budget for a multi-year partnership and can dedicate a team to data preparation and validation
Your primary focus is oncology and you need biomarker discovery for patient stratification in clinical trials

Choose Euretos AI Platform if

You want to quickly explore existing scientific knowledge to find drug repurposing opportunities or new targets
You need a secure, enterprise environment where your team can collaborate on in-silico research
You value evidence traceability — every connection in your analysis must be backed by published literature or data
You have a dedicated bioinformatics team that can learn a complex query language and custom data mapping

Key differences

BERG requires your own multi-omics data; Euretos comes with a massive pre-built knowledge graph
BERG uses causal AI to find root causes; Euretos uses knowledge graph analytics to find associations
BERG's onboarding is a multi-phase partnership (months); Euretos is a SaaS platform with training (weeks)
BERG has a proprietary human biobank; Euretos integrates public and licensed data sources
Both lack mobile apps and public APIs, but Euretos supports more input file formats (CSV, JSON, VCF, FASTA)
BERG is stronger for oncology and biomarker discovery; Euretos is more general across therapeutic areas

Facts side by side

	BERG (BPGbio)	Euretos AI Platform
Free plan
Mobile app
API access

BERG (BPGbio): strengths & weaknesses

Can find truly novel drug targets by understanding cause-and-effect in biology, not just correlations
Backed by a massive proprietary human biobank, giving it unique data others don't have
Strong track record in oncology with real clinical-stage assets
Not usable on a phone or as a simple web app — it's a full partnership, not a tool you buy
Requires you to supply your own high-quality multi-omics data, which most small labs don't have
Pricing is unpublished and almost certainly very expensive, with no self-service option
Onboarding takes months and involves multiple phases of data preparation and validation

Euretos AI Platform: strengths & weaknesses

Comes with a huge, pre-integrated knowledge graph so you can start exploring connections immediately
Every finding is traceable back to original sources, which is great for regulatory and publication needs
Supports multiple input formats (text, CSV, JSON, genomic files) making it flexible for different data types
The user interface is complex and requires dedicated training — not something you can just open and use
Pricing is not public and likely high, with no free tier or trial for individuals
No mobile app or public API, so you're tied to a desktop browser in a secure environment
Custom data mapping takes time and often needs help from their team

Common questions

Can I use BERG (BPGbio) or Euretos AI Platform on my phone?

No. Neither tool has a mobile app or mobile-friendly interface. Both are designed for desktop use in secure enterprise environments.

Which is better for a small biotech startup with limited data?

Euretos is the better choice because it comes with a pre-integrated knowledge graph, so you don't need your own massive dataset. BERG requires you to supply high-quality multi-omics data, which most startups don't have.

Is BERG (BPGbio) better than Euretos AI Platform for drug repurposing?

Euretos is better for drug repurposing because its knowledge graph connects drugs, diseases, and genes from existing literature, making it easier to spot repurposing opportunities. BERG is stronger for discovering entirely new targets from scratch.

How much do these tools cost?

Neither company publishes pricing. Both are enterprise-level products with costs likely in the tens to hundreds of thousands of dollars per year. There are no free tiers or trials for individuals.

Do I need to know how to code to use Euretos AI Platform?

Yes, for advanced use. The platform has a custom query language and requires training. Basic exploration might be possible through the UI, but full power requires bioinformatics skills.

Both BERG and Euretos are powerful but inaccessible to everyday users — Euretos wins for broader accessibility with its pre-built knowledge graph, while BERG is a niche choice for data-rich pharma teams needing causal AI.

If you're a non-technical person or a small team, neither of these tools is for you — they're built for large pharma with big budgets and dedicated data scientists. For everyday users, look at simpler AI tools like ChatGPT for literature summaries or cloud-based bioinformatics platforms with free tiers. If you are in a position to use one, Euretos is more accessible because it comes with data built in, while BERG is only for those who already have rich multi-omics datasets.

Visit BERG (BPGbio) Visit Euretos AI Platform

Detail pages: BERG (BPGbio) · Euretos AI Platform

BERG (BPGbio)

Euretos AI Platform

Free plan

Mobile app

API access